Piero Olliaro to Male
This is a "connection" page, showing publications Piero Olliaro has written about Male.
Connection Strength
0.087
-
An international qualitative study exploring patients' experiences of cutaneous leishmaniasis: study set-up and protocol. BMJ Open. 2018 06 15; 8(6):e021372.
Score: 0.010
-
Eligibility criteria and outcome measures adopted in clinical trials of treatments of cutaneous leishmaniasis: systematic literature review covering the period 1991-2015. Trop Med Int Health. 2018 05; 23(5):448-475.
Score: 0.010
-
Breast tuberculosis in men: A systematic review. PLoS One. 2018; 13(4):e0194766.
Score: 0.010
-
Effects on the QT Interval of a Gatifloxacin-Containing Regimen versus Standard Treatment of Pulmonary Tuberculosis. Antimicrob Agents Chemother. 2017 07; 61(7).
Score: 0.010
-
Efficacy and safety of praziquantel 40 mg/kg in preschool-aged and school-aged children: a meta-analysis. Parasit Vectors. 2017 01 26; 10(1):47.
Score: 0.009
-
Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19. Clin Exp Allergy. 2021 09; 51(9):1107-1120.
Score: 0.003
-
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study. Lancet. 2021 07 17; 398(10296):223-237.
Score: 0.003
-
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study. Lancet Respir Med. 2021 04; 9(4):349-359.
Score: 0.003
-
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ. 2020 09 09; 370:m3339.
Score: 0.003
-
Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. BMJ. 2020 08 27; 370:m3249.
Score: 0.003
-
The diagnosis and treatment of urogenital schistosomiasis in Italy in a retrospective cohort of immigrants from Sub-Saharan Africa. Infection. 2019 Jun; 47(3):447-459.
Score: 0.003
-
Barriers of Visceral Leishmaniasis reporting and surveillance in Nepal: comparison of governmental VL-program districts with non-program districts. Trop Med Int Health. 2019 02; 24(2):192-204.
Score: 0.003
-
A comparison of Zika and dengue outbreaks using national surveillance data in the Dominican Republic. PLoS Negl Trop Dis. 2018 11; 12(11):e0006876.
Score: 0.003
-
High-level artemisinin-resistance with quinine co-resistance emerges in P. falciparum malaria under in vivo artesunate pressure. BMC Med. 2018 10 01; 16(1):181.
Score: 0.003
-
Scaling down of a deworming programme among school-age children after a thirty-year successful intervention in the Bolivian Chaco. Trop Med Int Health. 2018 06; 23(6):616-621.
Score: 0.003
-
A multicentre, randomised, non-inferiority clinical trial comparing a nifurtimox-eflornithine combination to standard eflornithine monotherapy for late stage Trypanosoma brucei gambiense human African trypanosomiasis in Uganda. Parasit Vectors. 2018 02 22; 11(1):105.
Score: 0.003
-
Seroepidemiological trend of strongyloidiasis in the Bolivian Chaco (1987-2013) in the absence of disease-specific control measures. Trop Med Int Health. 2017 11; 22(11):1457-1462.
Score: 0.002
-
Systematic review of clinical trials assessing the therapeutic efficacy of visceral leishmaniasis treatments: A first step to assess the feasibility of establishing an individual patient data sharing platform. PLoS Negl Trop Dis. 2017 Sep; 11(9):e0005781.
Score: 0.002